ATOMWISE
Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster. Learn more at atomwise.com, or connect on Twitter and LinkedIn.
ATOMWISE
Industry:
Artificial Intelligence (AI) Biotechnology Health Care Machine Learning Medical Pharmaceutical
Founded:
2012-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.atomwise.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
176.65 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Analytics Content Delivery Network SSL By Default
Similar Organizations
AccutarBio
AccutarBio employs artificial intelligence to revolutionize drug discovery.
Alzheimer's Consulting & Services
Digital Drug R&D, Artificial Intelligence, Alzheimer's Disease Diagnosis and Therapeutics.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Swoop
Swoop uses privacy-safe advanced technology and AI to find, activate, engage and optimize ideal DTC and HCP audiences.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Atomwise
Tencent
Tencent investment in Series B - Atomwise
Sanabil
Sanabil investment in Series B - Atomwise
AME Cloud Ventures
AME Cloud Ventures investment in Series B - Atomwise
DCVC
DCVC investment in Series B - Atomwise
Y Combinator
Y Combinator investment in Series B - Atomwise
Colorcon
Colorcon investment in Series B - Atomwise
Dolby Family Ventures
Dolby Family Ventures investment in Series B - Atomwise
Baidu Ventures
Baidu Ventures investment in Series B - Atomwise
Touchdown Ventures
Touchdown Ventures investment in Series B - Atomwise
Newest Events participated
Participated in Y Combinator Winter 2015 Demo Day
on 2015-03-23 as exhibitor
Key Employee Changes
Official Site Inspections
http://www.atomwise.com Semrush global rank: 3.6 M Semrush visits lastest month: 3.58 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Atomwise"
Atomwise - Crunchbase Company Profile & Funding
Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates …See details»
Company – Atomwise
We are a technology-enabled pharmaceutical company leveraging the power of AI to revolutionize small molecule drug discovery. Our team invented the use of deep learning for structure-based …See details»
Our Leadership - Atomwise
Gavin Hirst, Ph.D., joined Atomwise as Chief Scientific Officer in September 2022 and leads all Atomwise drug discovery efforts. He brings over 30 years of drug discovery experience both in …See details»
Atomwise - Company Profile & Staff Directory - ContactOut
Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. Atomwise has strengthened its drug discovery and development expertise by expanding its …See details»
Atomwise Company Profile 2024: Valuation, Funding
Who are Atomwise’s competitors? Verge Genomics, Enterprise Therapeutics, PlantForm, Avidity Biosciences, and Sygnature Discovery are some of the 32 competitors of Atomwise. Data Transparency. Meet our data hygiene team. …See details»
Atomwise Information - RocketReach
Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster. We’re at a critical time in history where our need for new …See details»
Atomwise - LinkedIn
Atomwise | 21,158 followers on LinkedIn. Better Medicines Faster | Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. Atomwise has strengthened its drug ...See details»
Atomwise - Contacts, Employees, Board Members, Advisors
Organization. Atomwise . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... About. Atomwise has 13 current employee profiles, …See details»
Atomwise - Company Profile - Tracxn
Aug 17, 2021 Atomwise - Provider of a structure based drug designing platform using AI. Raised a total funding of $174M over 7 rounds from 29 investors. Founded by Abraham Heifets and …See details»
Atomwise - VentureRadar
Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. We invented the use of deep learning for structure-based drug discovery, today developing a …See details»
Atomwise - Pharmaceutical Technology
Atomwise’s AtomNet technology harnesses robust deep learning algorithms and supercomputers to examine millions of molecules for potential treatments. The company works in partnership …See details»
AI company Atomwise’s founding CEO exits, casting doubt over …
Oct 2, 2024 Atomwise’s founding CEO Abraham Heifets has left the company after a dozen years, Endpoints News has learned, in the latest challenge for one of the first AI-focused …See details»
AtomNet® Technology has the Power to Impact Early Drug
Atomwise is revolutionizing how drugs are discovered with AI. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule …See details»
Behind the AI: Reconfiguring Key Code to Supercharge ... - Atomwise
Atomwise is revolutionizing how drugs are discovered with AI. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule …See details»
Atomwise Adds Pharma Luminaries to Board of Directors and …
Jun 17, 2021 Experts include Mike Varney, Bruce Roth, John Hamer, Kemal Malik, and Andrew Lo. SAN FRANCISCO, Calif., June 17, 2021 – Atomwise has strengthened its drug discovery …See details»
Atomwise - University of Toronto Entrepreneurship
Atomwise Inc. patented the first deep learning technology for structure-based small molecule drug discovery. This AI technology harnesses millions of data points and thousands of protein …See details»
Atomwise Strengthens its Management Team, Adds Veteran …
Jan 25, 2022 CSO, CFO, and GC added as technology-enabled pharma company bolsters growing management team and SAB. SAN FRANCISCO, Calif. — January 25, 2022 — …See details»
Neglected Disease Program Reimagines Drug Discovery with
May 19, 2021 Perry runs the organization’s Neglected Tropical Diseases ... Atomwise also sends winners dozens of small molecule compounds for follow-up functional testing. So far, …See details»
A look back at NEOWISE, the NASA mission that cataloged objects …
1 day ago The NASA project NEOWISE, which has given astronomers a detailed view of near-Earth objects – some of which could strike the Earth – ended its mission and burned on re …See details»
Life at Atomwise – Atomwise
Atomwise is pioneering how machine learning and artificial intelligence are revolutionizing drug discovery. I am humbled by the diversity of our teams, and value how we collaborate, …See details»